Laparoscopic fertility-sparing surgery for early ovarian malignancies
The demand for fertility-sparing surgery (FSS) has increased in the last decade due to increased maternal age, increased incidence of ovarian malignancies in younger patients, and technical advances in surgery. Data on oncological safety and fertility outcomes of patients with ovarian cancer after l...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 October 2023
|
| In: |
Cancers
Year: 2023, Jahrgang: 15, Heft: 20, Pages: 1-15 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers15205099 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers15205099 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/15/20/5099 
|
| Verfasserangaben: | Julia S.M. Zimmermann, Pauline Ramisch, Marc P. Radosa, Christoph G. Radosa, Askin C. Kaya, Sara Y. Brucker, Florin A. Taran, Uwe A. Ulrich, Andreas Hackethal, Martin Deeken, Marc Sütterlin, Benjamin Tuschy, Erich-Franz Solomayer and Julia C. Radosa |
| Zusammenfassung: | The demand for fertility-sparing surgery (FSS) has increased in the last decade due to increased maternal age, increased incidence of ovarian malignancies in younger patients, and technical advances in surgery. Data on oncological safety and fertility outcomes of patients with ovarian cancer after laparoscopic FSS are sparse, but some retrospective studies have shown that open FSS may be offered to selected patients. We assessed the role of minimally invasive FSS in comparison with radical surgery (RS) in terms of oncological safety and reproductive outcomes after FSS in this multicenter study. Eighty patients with FIGO stage I/II ovarian cancer treated with laparoscopic FSS or RS between 01/2000 and 10/2018 at the participating centers (comprehensive gynecological cancer centers with minimally invasive surgical expertise) were included in this retrospective analysis of prospectively kept data. Case-control (n = 40 each) matching according to the FIGO stage was performed. Progression-free survival [150 (3-150) and 150 (5-150) months; p = 0.61] and overall survival [36 (3-150) and 50 (1-275) months; p = 0.65] did not differ between the FSS and RS groups. Eight (25.8%) women became pregnant after FSS, resulting in seven (22.5%) deliveries; three (37.5%) patients conceived after in vitro fertilization, and five (62.5%) conceived spontaneously. Laparoscopic FSS seems to be applicable and oncologically safe for patients with early-stage ovarian cancer, with adequate fertility outcomes. |
|---|---|
| Beschreibung: | Gesehen am 07.05.2024 |
| Beschreibung: | Online Resource |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers15205099 |